Neuronetics, Inc. has responded to correspondence from Pointillist Family Office regarding the company’s valuation. The Board and management team said they are committed to acting in the best interests of all shareholders and regularly evaluate opportunities to maximize shareholder value.
In reviewing the letter from the family office shareholder, Neuronetics agreed that the current valuation does not fully reflect the strength of the company’s business. The Board stated it is open to constructive engagement with its shareholders as the company executes on its strategic priorities to enhance long-term value.
Neuronetics is a global leader in neuroscience delivering treatment options through NeuroStar Advanced Therapy, a non-drug, noninvasive treatment that can improve quality of life for people suffering from neurohealth conditions when traditional medication has not helped. The company operates Greenbrook TMS Inc. treatment centers across the United States, offering NeuroStar Advanced Therapy for the treatment of major depressive disorder and other mental health disorders. NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation treatment for major depressive disorder in adults, backed by the largest clinical data set of any TMS treatment system for depression. Greenbrook treatment centers also offer SPRAVATO esketamine nasal spray, indicated for treatment-resistant depression and depressive symptoms in adults with major depressive disorder experiencing acute suicidal ideation or behavior.
The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration for adults with major depressive disorder, as an adjunct for adults with obsessive-compulsive disorder, to decrease anxiety symptoms in adult patients with depression, and as a first-line adjunct for treatment of major depressive disorder in adolescent patients aged 15-21.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://menafn.com/1110951151/Neuronetics-Comments-On-Letter-From-Pointillist-Family-Office